No Data
US Stock MarketDetailed Quotes
ACOR Acorda Therapeutics
Watchlist
15.9600
+0.3400+2.18% Trading 09/25 15:47 ET
16.2200High15.4101Low3.94KVolume
15.7000Open15.6200Pre Close61.82KTurnover0.33%Turnover Ratio1.69P/E (TTM)19.82MMarket Cap24.800052wk HighLossP/E (Static)1.24MShares5.800052wk Low0.29P/B19.28MFloat Cap5454.0000Historical High--Dividend TTM1.21MShs Float5.2220Historical Low--Div YieldTTM5.19%Amplitude15.6980Avg Price1Lot Size
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Acorda Therapeutics Company
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its products include Inbrija (levodopa inhalation powder), Ampyra (dalfampridine), Fampyra (fampridine), and Selincro (nalmefene). The firm's also offers Research and Development Programs like ARCUS for acute migraine, Cimaglermin alfa, and rHIgM22. The company was founded by Ronald Cohen in 1995 and is headquartered in New York, NY.
Revenue Breakdown
Business
Unit:USD
12/31/2022
Stock NameRevenueRatio
Net product revenues103.85M87.58%
Royalty revenues14.22M11.99%
License revenue500K0.42%
News
Overview Of Value Stocks In The Healthcare Sector
The Meaning Behind Value StocksA value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base i
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersNanoVibronix (NASDAQ:NAOV) stock increased by 71.0% to $2.48 during Wednesday's pre-market session. The company's market cap stands at $4.1 million. Aravive (NASDAQ:ARAV) stock moved upwards by
Acorda Therapeutics (ACOR): A Comprehensive Analysis of Its Market Value
Comments
Future Movement the crucial last few months of the year
Hello everyone,
We're seeking community insights on the potential movement of this stock in the coming one to two months. Do you anticipate it to rise or fall?
If you have any solid ideas, insider information, or news that might influence this stock's direction, kindly share in the comments section below. Your input is greatly valued!
Thank you for your participation.
$Acorda Therapeutics(ACOR.US$
We're seeking community insights on the potential movement of this stock in the coming one to two months. Do you anticipate it to rise or fall?
If you have any solid ideas, insider information, or news that might influence this stock's direction, kindly share in the comments section below. Your input is greatly valued!
Thank you for your participation.
$Acorda Therapeutics(ACOR.US$
June whole market recently RS update
$Lixte Biotechnology(LIXT.US$ 700k float / 60% institutional /67% CTB
$Grove Collaborative(GROV.US$ 16m float / 74% institutional/ 30% CTB
$Acorda Therapeutics(ACOR.US$ 1.2m float/ 18% institutional/ 37% CTB
$Verastem(VSTM.US$ 16m float / 40% institutional/ 18% CTB
$Cibus Inc(CBUS.US$ 16m float / 12% institutional
$Bone Biologics(BBLG.US$ 27m float / 17% institutional/ 127% CTB
$Greenlane(GNLN.US$ 1.5m float/ 17% institutional/ 35% CTB
$VistaGen Therapeutics(VTGN.US$ 7.2m floa...
$Grove Collaborative(GROV.US$ 16m float / 74% institutional/ 30% CTB
$Acorda Therapeutics(ACOR.US$ 1.2m float/ 18% institutional/ 37% CTB
$Verastem(VSTM.US$ 16m float / 40% institutional/ 18% CTB
$Cibus Inc(CBUS.US$ 16m float / 12% institutional
$Bone Biologics(BBLG.US$ 27m float / 17% institutional/ 127% CTB
$Greenlane(GNLN.US$ 1.5m float/ 17% institutional/ 35% CTB
$VistaGen Therapeutics(VTGN.US$ 7.2m floa...
36
22
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--